Oragenics (OGEN) Competitors $0.19 0.00 (-1.07%) Closing price 04:00 PM EasternExtended Trading$0.19 -0.01 (-3.54%) As of 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock OGEN vs. BFRG, BCTX, LPTX, BIVI, MIRA, GLYC, ABVC, NRSN, COCP, and PHIOShould you be buying Oragenics stock or one of its competitors? The main competitors of Oragenics include Bullfrog AI (BFRG), BriaCell Therapeutics (BCTX), Leap Therapeutics (LPTX), BioVie (BIVI), MIRA Pharmaceuticals (MIRA), GlycoMimetics (GLYC), ABVC BioPharma (ABVC), NeuroSense Therapeutics (NRSN), Cocrystal Pharma (COCP), and Phio Pharmaceuticals (PHIO). These companies are all part of the "pharmaceutical products" industry. Oragenics vs. Bullfrog AI BriaCell Therapeutics Leap Therapeutics BioVie MIRA Pharmaceuticals GlycoMimetics ABVC BioPharma NeuroSense Therapeutics Cocrystal Pharma Phio Pharmaceuticals Oragenics (NYSE:OGEN) and Bullfrog AI (NASDAQ:BFRG) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, community ranking, valuation, dividends, risk and institutional ownership. Do institutionals & insiders have more ownership in OGEN or BFRG? 18.7% of Oragenics shares are owned by institutional investors. Comparatively, 1.0% of Bullfrog AI shares are owned by institutional investors. 10.1% of Oragenics shares are owned by company insiders. Comparatively, 33.9% of Bullfrog AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Is OGEN or BFRG more profitable? Bullfrog AI's return on equity of -141.39% beat Oragenics' return on equity.Company Net Margins Return on Equity Return on Assets OragenicsN/A -2,087.95% -486.56% Bullfrog AI N/A -141.39%-124.63% Does the MarketBeat Community believe in OGEN or BFRG? Oragenics and Bullfrog AI both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformOragenicsOutperform VotesNo VotesUnderperform Votes53100.00% Bullfrog AIN/AN/A Which has more volatility & risk, OGEN or BFRG? Oragenics has a beta of 0.87, indicating that its share price is 13% less volatile than the S&P 500. Comparatively, Bullfrog AI has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Does the media prefer OGEN or BFRG? In the previous week, Oragenics had 1 more articles in the media than Bullfrog AI. MarketBeat recorded 2 mentions for Oragenics and 1 mentions for Bullfrog AI. Bullfrog AI's average media sentiment score of 0.43 beat Oragenics' score of 0.00 indicating that Bullfrog AI is being referred to more favorably in the news media. Company Overall Sentiment Oragenics Neutral Bullfrog AI Neutral Which has higher earnings & valuation, OGEN or BFRG? Bullfrog AI has higher revenue and earnings than Oragenics. Bullfrog AI is trading at a lower price-to-earnings ratio than Oragenics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOragenics$40K104.64-$20.66M-$1.70-0.11Bullfrog AI$60K284.02-$5.36M-$0.86-2.10 SummaryBullfrog AI beats Oragenics on 8 of the 12 factors compared between the two stocks. Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGEN vs. The Competition Export to ExcelMetricOragenicsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$4.19M$6.84B$5.55B$19.23BDividend YieldN/A2.95%5.09%4.00%P/E Ratio-0.037.4422.6833.45Price / Sales104.64257.63404.2829.18Price / CashN/A65.8538.1817.52Price / Book0.326.576.794.55Net Income-$20.66M$143.14M$3.22B$1.02B7 Day Performance-1.07%3.60%2.44%2.18%1 Month Performance-2.50%6.01%3.79%-2.05%1 Year Performance-81.44%-2.02%17.06%5.45% Oragenics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGENOragenicsN/A$0.19-1.1%N/A-80.7%$4.19M$40,000.00-0.035Analyst ForecastNews CoverageBFRGBullfrog AI0.4678 of 5 stars$1.66flatN/A-42.7%$15.63M$60,000.00-1.954Upcoming EarningsShort Interest ↑BCTXBriaCell Therapeutics1.7331 of 5 stars$4.19-2.3%$32.00+663.7%-87.0%$15.54MN/A-0.318Gap DownLPTXLeap Therapeutics2.4801 of 5 stars$0.36-1.0%$4.92+1,267.3%-87.3%$14.84MN/A-0.1940BIVIBioVie2.8335 of 5 stars$0.79-5.6%$3.00+277.8%+74.8%$14.65MN/A-0.0810Short Interest ↓Gap UpMIRAMIRA Pharmaceuticals2.9217 of 5 stars$0.87-7.9%$14.00+1,518.5%+39.1%$14.54MN/A-1.542Short Interest ↓GLYCGlycoMimetics2.1116 of 5 stars$0.22-1.3%N/A-83.8%$14.19M$10,000.00-0.3750Upcoming EarningsAnalyst ForecastShort Interest ↓News CoverageGap DownABVCABVC BioPharma0.7281 of 5 stars$0.87+2.1%N/A-8.8%$13.77M$509,788.00-1.0130Earnings ReportNRSNNeuroSense Therapeutics1.3601 of 5 stars$1.00-3.2%N/A-17.6%$13.67MN/A-1.5610Short Interest ↓COCPCocrystal Pharma2.5594 of 5 stars$1.34+1.9%$7.00+424.2%+3.9%$13.58MN/A-0.7210Gap UpPHIOPhio Pharmaceuticals2.5192 of 5 stars$2.83+3.7%$4.00+41.3%-72.3%$13.52MN/A-0.2610Upcoming Earnings Related Companies and Tools Related Companies Bullfrog AI Competitors BriaCell Therapeutics Competitors Leap Therapeutics Competitors BioVie Competitors MIRA Pharmaceuticals Competitors GlycoMimetics Competitors ABVC BioPharma Competitors NeuroSense Therapeutics Competitors Cocrystal Pharma Competitors Phio Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OGEN) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Musk is all in on these robots …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OGEN Stock Free OGEN Stock Alerts